HomeCVKD • NASDAQ
add
Cadrenal Therapeutics Inc
Previous close
$16.32
Day range
$15.46 - $16.76
Year range
$5.70 - $22.90
Market cap
30.08M USD
Avg Volume
29.95K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.28M | 238.53% |
Net income | -4.19M | -266.00% |
Net profit margin | — | — |
Earnings per share | -8.73 | -365.60% |
EBITDA | -4.28M | -238.66% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 10.02M | 19.23% |
Total assets | 10.12M | 18.83% |
Total liabilities | 2.68M | 224.59% |
Total equity | 7.44M | — |
Shares outstanding | 1.88M | — |
Price to book | 3.91 | — |
Return on assets | -144.51% | — |
Return on capital | -197.09% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -4.19M | -266.00% |
Cash from operations | -1.79M | -157.86% |
Cash from investing | -6.54K | — |
Cash from financing | 7.45M | 59,710.28% |
Net change in cash | 5.65M | 899.79% |
Free cash flow | -283.96K | 16.56% |
About
Founded
2022
Website
Employees
4
